235 related articles for article (PubMed ID: 31534142)
1. Epigenome editing strategies for the functional annotation of CTCF insulators.
Tarjan DR; Flavahan WA; Bernstein BE
Nat Commun; 2019 Sep; 10(1):4258. PubMed ID: 31534142
[TBL] [Abstract][Full Text] [Related]
2. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
4. Editing DNA Methylation in the Mammalian Genome.
Liu XS; Wu H; Ji X; Stelzer Y; Wu X; Czauderna S; Shu J; Dadon D; Young RA; Jaenisch R
Cell; 2016 Sep; 167(1):233-247.e17. PubMed ID: 27662091
[TBL] [Abstract][Full Text] [Related]
5. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
[TBL] [Abstract][Full Text] [Related]
6. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
[TBL] [Abstract][Full Text] [Related]
7. Targeted DNA methylation in human cells using engineered dCas9-methyltransferases.
Xiong T; Meister GE; Workman RE; Kato NC; Spellberg MJ; Turker F; Timp W; Ostermeier M; Novina CD
Sci Rep; 2017 Jul; 7(1):6732. PubMed ID: 28751638
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation-independent removable insulator controls chromatin remodeling at the HOXA locus via retinoic acid signaling.
Ishihara K; Nakamoto M; Nakao M
Hum Mol Genet; 2016 Dec; 25(24):5383-5394. PubMed ID: 27798106
[TBL] [Abstract][Full Text] [Related]
9. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
[TBL] [Abstract][Full Text] [Related]
10. The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural Boundaries.
Hsu SC; Gilgenast TG; Bartman CR; Edwards CR; Stonestrom AJ; Huang P; Emerson DJ; Evans P; Werner MT; Keller CA; Giardine B; Hardison RC; Raj A; Phillips-Cremins JE; Blobel GA
Mol Cell; 2017 Apr; 66(1):102-116.e7. PubMed ID: 28388437
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
[TBL] [Abstract][Full Text] [Related]
12. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing.
O'Geen H; Tomkova M; Combs JA; Tilley EK; Segal DJ
Nucleic Acids Res; 2022 Apr; 50(6):3239-3253. PubMed ID: 35234927
[TBL] [Abstract][Full Text] [Related]
13. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
[TBL] [Abstract][Full Text] [Related]
14. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
[TBL] [Abstract][Full Text] [Related]
15. dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression.
O'Geen H; Ren C; Nicolet CM; Perez AA; Halmai J; Le VM; Mackay JP; Farnham PJ; Segal DJ
Nucleic Acids Res; 2017 Sep; 45(17):9901-9916. PubMed ID: 28973434
[TBL] [Abstract][Full Text] [Related]
16. Efficient Targeted DNA Methylation with dCas9-Coupled DNMT3A-DNMT3L Methyltransferase.
Bashtrykov P; Rajaram N; Jeltsch A
Methods Mol Biol; 2023; 2577():177-188. PubMed ID: 36173573
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated gene knockout for DNA methyltransferase Dnmt3a in CHO cells displays enhanced transgenic expression and long-term stability.
Jia YL; Guo X; Lu JT; Wang XY; Qiu LL; Wang TY
J Cell Mol Med; 2018 Sep; 22(9):4106-4116. PubMed ID: 29851281
[TBL] [Abstract][Full Text] [Related]
18. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
Lau CH; Suh Y
Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
20. Identification of Cancer Drivers at CTCF Insulators in 1,962 Whole Genomes.
Liu EM; Martinez-Fundichely A; Diaz BJ; Aronson B; Cuykendall T; MacKay M; Dhingra P; Wong EWP; Chi P; Apostolou E; Sanjana NE; Khurana E
Cell Syst; 2019 May; 8(5):446-455.e8. PubMed ID: 31078526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
